Funding Opportunity for Effects of Vagus Nerve Stimulation The NIH Common FundsStimulating Peripheral Activity to Relieve Conditions (SPARC)program aims toaccelerate development of therapeutic devices that modulate electrical activity in nerves to improve organ function. This newSPARCFunding Opportunity:RFA-RM-22-002:SPARCVNS Endpoints from Standardized Parameters (VESPA)aims tosupportalarge multisite study of the multi-organ effects ofvagusnerve stimulation(VNS)in humans.TheVESPACenterwillimplement a common study protocolofdirectstimulation of the cervicalvagusnervein participants with implanted VNSdevices andwill document and analyze the physiological outcomesfrom at least three peripheral physiological systems.The datafrom this studywillhelpinform the optimization of VNS treatment by providingkey informationonthe functional connectivity of the humanvagusnerve. Funding Opportunity Announcement RFA-RM-22-002:SPARCVNS Endpoints from Standardized Parameters (VESPA)(U54 Clinical Trial Required 1st Informational Webinar: TODAYJanuary 21,2022at 4:00 p.m. ET- Register Save the Dates Checkthe SPARC Scientific Meetings webpagefor additional updates 2nd Informational Webinar:February 2,2022 (registration coming soon) Team-Building Webinar:February 18,2022 (registration coming soon) Important Dates Letter of Intent Due Date:March 2, 2022(not required, but strongly encouraged) Application Due Date:April 1,2022by 5:00 p.m. local time of applicant organization You canfind answers toFrequentlyAskedQuestions(FAQs)andlearn more about the programon theSPARC website.Wealsoencourage you to sign up for theSPARC listservto keep up to date with the latest SPARC news and information. | 